Background Image
Table of Contents Table of Contents
Previous Page  57 / 112 Next Page
Information
Show Menu
Previous Page 57 / 112 Next Page
Page Background

55

WFSBP 2015

Tuesday, 16 June 2015

|

Scientific Programme

P-11-012

ABCB1 polymorphism may be related to refractoriness

in a sample of mood disorders patients undergoing ECT:

A pharmacogenetics approach

Carolina Prado, Brazil

M. van de Bilt, B. Valim de Nicola, L. Rigonatti, S. Rigonatti,

L. Talib, W. Gattaz

P-11-013

Are HTR1A and HTR2A polymorphisms related to treatment

response? A pharmacogenetics study of ECT patients

Bruna Nicola, Brazil

C. Prado, M. van de Bilt, L. Rigonatti, L. Talib, S. Rigonatti,

W. Gattaz

P-11-014

Deep brain stimulation alters expression of blood brain

barrier transporters as a mechanism to enhance CNS drug

effects

Ziad Nahas, Lebanon

L. Devane, M. Doumit, P. Zhang

P-11-015

Efficacy of repetitive transcranial magnetic stimulation

(rtms) in post traumatic stress disorder (ptsd) and panic

disorder: A meta-analysis

Deepa Nathan, India

M. S. Keshavan

P-11-016

Longitudinal efficacy of tms treatment in depression

Oguz Karamustafalioglu, Turkey

M. Cevik, O. Tankaya

P-12

Poster Presentation

12:45–14:15

Muses Foyer

Basic and Clinical Neuroscience/Epidemiology

Chair:

Maria Panayotacopoulou, Greece

Co-Chair: Margarita Chryssanthou-Piterou, Greece

P-12-001

Ketamine as a model for schizophrenia deficits

Erica Neill, Australia

S. Rossell, C. Morgan, O. Carter, N. Joshua

P-12-003

Emotion processing in schizophrenia patients and their

unaffected mothers

Natallia Khamenka, Belarus

M. Skuhareuskaya, O. Skugarevsky

P-12-004

Mentalizing in schizophrenia: Abnormal activation of theory

of mind areas during implicit perspective taking

Lisa Mayrhauser, Austria

M. Tschernegg, L. A. Nawara, M. Schurz, J. S. Crone, R. Stel-

zig-Schöler, C. Geretsegger, M. Kronbichler

P-12-005

Neurocognition and serotonin transporter 5-HTTLPR poly­

morphism in high-risk for psychosis individuals

Maryna Skuhareuskaya, Belarus

I. Halayenka

P-12-006

The modulatory role of serotonin in model-based and mo­

del-free choice behaviour

Nikolina Skandali, United Kingdom

V. Voon, A. Bruhl, J. Rowe, T. Robbins, B. Sahakian

P-12-007

Co-prescription of antipsychotics with other psychotropics

and medication for somatic disorders: A total population

study in Austria

Heinz Katschnig, Austria

F. Endel, C. Strassmayr

P-12-008

Genetic ancestry of psychosis in the population of the Cen-

tral Valley of Costa Rica

Javier Contreras, Costa Rica

R. Barrantes, H. Raventos

P-12-009

Pattern of gene expression in different stages of schizo-

phrenia: A pilot comparison of human induced pluripotent

stem cell-derived neurons with post mortem cerebral cortex

Mirko Manchia, Italy

I. S. Piras, C. C. Zai, J. Kennedy, B. Carpiniello

P-12-011

Linkage and association analyses of schizophrenia with

genetic variations on chromosome 22q11 in Korean po­

pulation

Yu Sang Lee, Republic of Korea

K. S. Hong

P-12-012

Polymorphisms in the serotonin transporter gene and the

risk of stroke: An association study

Janne Kaergaard Mortensen, Denmark

H. Buttenschön, O. Mors, G. Andersen